Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Vaccine: X|August 7, 2019
rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/benefit assessmentThomas P Monath, Patricia E Fast, Kayvon Modjarrad, et al.Journal of Virological Methods|March 30, 2006
An efficient helper-virus-free method for rescue of recombinant paramyxoviruses and rhadoviruses from a cell line suitable for vaccine developmentSusan E Witko, Cheryl S Kotash, Rebecca M Nowak, et al.Molecular Therapy Oncolytics|July 13, 2018
Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPV<sup>POS</sup> CancersLukkana Suksanpaisan, Rong Xu, Mulu Z Tesfay, et al.Journal of Virology|April 14, 2006
Recombinant vesicular stomatitis virus vectors expressing herpes simplex virus type 2 gD elicit robust CD4+ Th1 immune responses and are protective in mouse and guinea pig models of vaginal challengeRobert J Natuk, David Cooper, Min Guo, et al.The Lancet. Infectious Diseases|January 19, 2020
Safety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccine: a randomised, double-blind, placebo-controlled, phase 1 clinical trialDavid K Clarke, Rong Xu, Demetrius Matassov, et al.Journal of Virology|November 17, 2017
Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus ChallengeDemetrius Matassov, Chad E Mire, Theresa Latham, et al.Vaccine|March 19, 2023
Cellular and humoral responses to an HIV DNA prime by electroporation boosted with recombinant vesicular stomatitis virus expressing HIV subtype C Env in a randomized controlled clinical trialGregory J Wilson, Benigno Rodriguez, Shuying Sue Li, et al.Plos One|September 21, 2018
Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trialMarnie L Elizaga, Shuying S Li, Nidhi K Kochar, et al.Journal of Virology|April 4, 2014
Neurovirulence and immunogenicity of attenuated recombinant vesicular stomatitis viruses in nonhuman primatesDavid K Clarke, Farooq Nasar, Siew Chong, et al.AIDS Research and Human Retroviruses|December 9, 2004
Immunogenicity of attenuated vesicular stomatitis virus vectors expressing HIV type 1 Env and SIV Gag proteins: comparison of intranasal and intramuscular vaccination routesMichael A Egan, Siew Yen Chong, Nina F Rose, et al.Pageof 3